-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 H8nfilR0QlUB20wBZgfb/qONLDZcIN+Q3d3fa+3+DhCdZcRQrCpH3l9NUWvD4jtX
 803ZO5HwPIw2wX2H2VfZaw==

<SEC-DOCUMENT>0000891020-03-002224.txt : 20030821
<SEC-HEADER>0000891020-03-002224.hdr.sgml : 20030821
<ACCEPTANCE-DATETIME>20030821115714
ACCESSION NUMBER:		0000891020-03-002224
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20030821
ITEM INFORMATION:		
ITEM INFORMATION:		Financial statements and exhibits
FILED AS OF DATE:		20030821

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TARGETED GENETICS CORP /WA/
		CENTRAL INDEX KEY:			0000921114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				911549568
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23930
		FILM NUMBER:		03859452

	BUSINESS ADDRESS:	
		STREET 1:		1100 OLIVE WAY
		STREET 2:		STE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
		BUSINESS PHONE:		2066237612

	MAIL ADDRESS:	
		STREET 1:		1100 OLIVE WAY
		STREET 2:		STE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v92650e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Targeted Genetics Corporation Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<P align="center"><FONT size="2">UNITED STATES
</FONT>

<P align="center"><FONT size="2">SECURITIES AND EXCHANGE COMMISSION
</FONT>

<P align="center"><FONT size="2">Washington, D.C. 20549
</FONT>

<P align="center"><FONT size="2"><B>FORM 8-K</B>
</FONT>

<P align="center"><FONT size="2"><B>CURRENT REPORT</B>
</FONT>

<P align="center"><FONT size="2"><B>Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</B>
</FONT>

<P align="center"><FONT size="2">Date of Report (Date of earliest event reported) August&nbsp;21, 2003
</FONT>

<P align="center"><FONT size="2">Targeted Genetics Corporation<BR>
<HR align="center" size="1" width="100%" noshade>
</FONT>

<DIV align="center"><FONT size="2">(Exact name of registrant as specified in charter)
</FONT></DIV>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">Washington</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
0-23930
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">91-1549568</FONT></TD>
</TR>
<TR>
    <TD colspan="5" align="center" valign="top"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">(State or other jurisdiction<BR>
of incorporation)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
(Commission<BR>
File Number)
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">(IRS Employer<BR>
Identification No.)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">1100 Olive Way, Suite&nbsp;100, Seattle, Washington</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">98101</FONT></TD>
</TR>
<TR>
    <TD colspan="3" align="center" valign="top"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">(Address of principal executive offices)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">(Zip Code)</FONT></TD>
</TR>
</TABLE>
</CENTER>

<P align="center"><FONT size="2">Registrant&#146;s telephone number, including area code (206)&nbsp;623-7612
</FONT>


<P align="center"><FONT size="2">Not Applicable<BR>
<HR align="center" size="1" width="45%" noshade>
</FONT>


<DIV align="center"><FONT size="2">(Former name or former address, if changed since last report)
</FONT></DIV>

<P align="center"><FONT size="2">1</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">Item&nbsp;7. Exhibits.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;12. Results and Operations of Financial Condition.</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="v92650exv99w1.htm">EXHIBIT 99.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link2 "Item&nbsp;7. Exhibits." -->
<DIV align="left"><A NAME="000"></A></DIV>

<P align="left"><FONT size="2"><B>Item&nbsp;7. Exhibits.</B>
</FONT>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="2">(a)</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="2">Financial statements of business acquired.</FONT></TD>
</TR>
<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="2">Not applicable.</FONT></TD>
</TR>
<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="2">(b)</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="2">Pro forma financial information.</FONT></TD>
</TR>
<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="2">&nbsp;</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="2">Not applicable.</FONT></TD>
</TR>
<TR>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="1%" align="left" nowrap><FONT size="2">(c)</FONT></TD>
    <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
    <TD width="93%"><FONT size="2">Exhibits.</FONT></TD>
</TR>
</TABLE>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Exhibit</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>No.</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Description</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">99.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Press Release of Targeted Genetics Corporation dated August&nbsp;21, 2003</FONT></TD>
</TR>
</TABLE>
</CENTER>
<!-- link2 "Item&nbsp;12. Results and Operations of Financial Condition." -->
<DIV align="left"><A NAME="001"></A></DIV>

<P align="left"><FONT size="2"><B>Item&nbsp;12. Results and Operations of Financial Condition.</B>
</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On August&nbsp;21, 2003, Targeted Genetics Corporation issued a press release
announcing the effectiveness of its registration statement on Form&nbsp;S-3. A copy
of the press release is furnished as Exhibit&nbsp;99.1 and is incorporated into this
current report by reference.
</FONT>

<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="002"></A></DIV>

<P align="center"><FONT size="2"><B>SIGNATURES</B>
</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="51%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="3" valign="top" align="left"><FONT size="2">TARGETED GENETICS CORPORATION</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: August&nbsp;21, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
By:
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">/s/ H. STEWART PARKER
<HR align="center" size="1" noshade>
H. Stewart Parker<br>
President and Chief Executive Officer<br>
(Principal Executive Officer)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="003"></A></DIV>

<P align="center"><FONT size="2">EXHIBIT INDEX
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="75%">
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Exhibit</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>No.</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Description</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">99.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Press Release of Targeted Genetics Corporation dated August&nbsp;21, 2003</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v92650exv99w1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="right"><FONT size="2"><B>Exhibit&nbsp;99. 1</B>
</FONT>


<P align="center"><FONT size="2"><IMG src="v92650v9265000.gif" alt="(TARGETED GENETICS LOGO)">&nbsp;&nbsp;<B>&#174;</B>
</FONT>

<P align="left"><FONT size="2"><B>Contact:</B><BR>
Targeted Genetics Corporation<BR>
Courtney Self<BR>
(206)&nbsp;521-7392
</FONT>

<P align="center"><FONT size="2"><B>TARGETED GENETICS ANNOUNCES EFFECTIVENESS<BR>
OF ITS SHELF REGISTRATION STATEMENT</B>
</FONT>

<P align="left"><FONT size="2"><B>Seattle, WA</B>&#151; August&nbsp;21, 2003&#151;Targeted Genetics Corporation (Nasdaq: TGEN)
announced today that its shelf registration statement on Form&nbsp;S-3 filed on
August&nbsp;11, 2003, has been declared effective by the U.S. Securities and
Exchange Commission (SEC). The shelf registration for the sale of up to
11,600,000 shares of its common stock will allow Targeted Genetics to sell
common stock from time to time in one or more offerings at its discretion. The
shelf registration is intended to provide flexibility in financing the
Company&#146;s business objectives going forward. Specific terms of any issuance of
common stock under this shelf registration would be established at the time of
sale.
</FONT>

<P align="left"><FONT size="2">This press release shall not constitute an offer to sell or the solicitation of
an offer to buy nor shall there be any sale of these securities in any state in
which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state.
</FONT>

<P align="left"><FONT size="2">A copy of the prospectus included in the registration statement is available in
the Investor Relations section of the Targeted Genetics website at
www.targetedgenetics.com, the SEC&#146;s website at www.sec.gov, or via written
request to Targeted Genetics Corporation, 1100 Olive Way, Suite&nbsp;100, Seattle,
Washington 98101, Attention: Investor Relations. In addition, Targeted Genetics
will file a prospectus supplement with the SEC in connection with any offering
under the shelf registration statement.
</FONT>

<P align="left"><FONT size="2">Targeted Genetics develops gene therapy products for treating acquired and
inherited diseases. The Company has a lead clinical product development program
targeting cystic fibrosis and a
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P align="left"><FONT size="2">promising pipeline of product candidates focused on arthritis, an AIDS vaccine,
hemophilia and cancer. The Company has a broad platform of gene delivery
technologies as well as a promising body of technology for cellular therapy.
For more information about Targeted Genetics Corporation, please visit the
Company&#146;s web site at http://www.targetedgenetics.com.
</FONT>

<P align="left"><FONT size="2"><I>NOTE: This release contains forward-looking statements regarding offerings of
our common stock in the future, which are based on opinions and estimates of
our management at the time the statements are made and are subject to risks and
uncertainties that could cause actual results to differ materially from those
expected or implied by these forward-looking statements. Inaccurate assumptions
and known and unknown risks and uncertainties can affect the accuracy of these
forward-looking statements. Factors that could affect our actual results
include, but are not limited to, market conditions that prevent us from
commencing or completing an offering on acceptable terms, if at all, changes in
our financing plan, changes in our business, as well as the other risk factors
described in the section entitled &#147;Factors Affecting Our Operating Results, Our
Business and Our Stock Price&#148; included in our report on Form&nbsp;10-Q for the
quarter ended June&nbsp;30, 2003. You should not rely unduly on these
forward-looking statements, which apply only as of the date of this release. We
undertake no obligation to reflect new information, circumstances or events
after the date of this release or to reflect the occurrence of unanticipated
events.</I>
</FONT>


<P align="center"><FONT size="2"><I>###</I>
</FONT>



<P align="center"><FONT size="2">&nbsp;</FONT>



</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>v92650v9265000.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v92650v9265000.gif
M1TE&.#EAB@"\`/<```!:2@!C2@!C4@!K4@!K6@!S6@!S8P![8P![:P"$:PA[
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M_____________________RP`````B@"\```(_@#_"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DR@17F'BA*7+EC!?RHQ)<Z;-
MFCAOZLS)<Z?/GD!EKE"S1@U1HT6/*DW*%*G3I4^;0ITJM6K4JU2Q6LW*U6J<
M#S92BAVKD$58LFC3KCB;MFW*M6[CGH3KL,\1*7CS3MDQ1Z[?A'0=4A!`@("!
M`@0&!(ACD`]2A&[41&Y39^$=-6WL'*R39DV;R$8+TBD3N709Q@332);<QDQE
M@G16O]$<,3!#/CJF9+%A@$*6+"S>--Y@(`1")@8.'%:PX;7!'PT.,U@A1C0$
MY08,$!A1,,N`[`BR_@]H4O!(]O,%JA,T$SY[@Q"T'=I^Z&6[0CKA%R!,8V##
MD2,C$+#!02<,0`%>%PR@'D$;'"#$$4,(X41!9=APQ`H%D,"$#5D4)(8!'_PW
MQ`]J%&2'`P[\]P$!"_#QT'P.94$`"`I=0<`)Z1UDA@$_#.0``@:9(>!`<9!G
MT`5`,N3%`%(@%$8!1RADQP(#"O0#`3W*QQ9$611`8T+$Q5'`E@.9,28?>UQA
MP`,&V3"`%W^X""8"89B1!1T):3$`$TX:,)08<!I4AP-5_K&'`(4R!&-#,AJ'
MT!P%]'C=064@4`!A!2!@AD$%YO$'"R,(\4.4!1$G0``$N)&0C'P>%,8!_@2<
MRIU!4R8Z``1R*DIFC`0X>A`38V9A`0$+EMD?$0\8D,9!*!!0(@P'P`J#01L@
MH`8=7L1G$*M]VD`''%ILQD"A?!!@P8N[,MHKF`8@@,`"!I@0I`$Z_'&%`"P<
ME(4`*_Q161@$[$!MD@MY-Z&K!`@A)94#73'`M%I.U"A"=A!PEA\/,*#M'SO6
M^T>RJAKD0`$GN/&&"01`S"`"91BEQA5['*1GJP:%80`,H(D1AHD,4*!&&CMD
MAV?$$ATQP`-^'/1#`#L+!(,`5G0G`,3W?K"9!0,,0)@#)1*TQP,%:*UU`3$;
M=$0`66Y;6-:GDAD'K%H3<,"FZ$YD1AIBE%V0_AEFH/9'470/]'.@<N"M=T%O
M2#%%R`7)T3)1JDEQN.!\)UWSST>%$2B19KC,>-U_A>[1HJ*73A'IIJ<.ND-\
MM.[ZZ[#'+OOLM-=N^^VXW]X'1*C73($-,,0@0_##"T_\\<8G7_SRR#.O?//0
M/R^]\]1'7[T-_JW.D)VJD^5&DT0W%,85W8]E!O@-];XW^N6?E,;!Z:>+$!E3
MM)_2^]HO=+[]*.$?/D-D(-]'RG"%+!3P@`9,(`(7J$`#BL5_\7O(&*+6$3R\
MH``%T,YA-FB8#&:P@QS<8`8'<(*4[.]_"Z%?1Z1@&'>Y\(4PC*$,P\,F]\%/
M5P\YH4;HD!WE1"LY_LGQH0^#",0?"I&(#Q@:272(0X<$D"-"V$`(0##%*E:1
MBE2\HA:UB,40;.`$DP,)!)O8D`GR[R1,7(CZ"*+",Y9DC&J4GX[8Y\:0P%$A
M:QS($S62!C.4@6]__*,?!SE(0082D(0\9"$1^4>_;>2.@)&C0<R($3[4X``*
M6$`F-[E)3792`9\,I28].4I0EO(`#X!#1]*(1TD6I(T7L4`#'D"!"41@`A1X
M`"YO:4M<ZI("M\SE+B?02V$"TY?#[.4#&M`U/MXPCCFD(T68H(`'6/.:#XC`
M-;6Y36QFLYO@#"<WE_F`96F$E9%\R!XO8H<1F."=[GRG">()3WG.TY[T_KRG
M///)3WA^8&,502="\B@02G;$<@1!Z!\4RM"$.G0@"MU=KBX"R8&ZDHWUJ^-(
M*GH0@G),FAKM"$<-XM%U9H0/;8@#'%3*TI6ZM*4P?:E,8TI3F4YT(B,MB$<-
MJA$:3"`#&=!`4(<JU*(2]:A&32I2ERK4"HB`"F%\2$X)4M*,;H0/(NA`"40@
M@JUVE:M>#2M8Q_K5LHK5K&/U:@6:AM-GMC*:'DE#!SJ0U;K2=:Y9O:M>\\I7
MO/IUKW^U:P4`*E6WIM.)`NS('%1`@QF\P+$S:"P-7-#8QTZVLI&E+&0ONUG-
M6M:SD9V!"BPRU8'LE((>>5T?5-NZU?+!M;!M_JUL7SO;V-+6=;NK2&D%4M60
MBF2W?_"H0'V;$>"6-+$F00,6NL#<YCKWN="-+G2Q8$[=&M:B$D2M2?S0@A2H
MP+O@_:YXPTO>\9HWO"7``D6OV]&+ZM&J)[$##5HP@QG0M[[WM6]]]8O?_>;W
MOS,H01O6FS^%#%<D<%!!"Q;,X`8[^,$09G`*EH`1X[I7("9%21MNT(,>X*`'
M/NAPB$$LX@^/^,0E!C$.H%!<]I+TPG_@:4KVL`<TU9C&-LXQCG=\XQZCR9D%
M3@@LB2M2%^L4Q@<FLG6#/#_D_@5-N8LJ:8U,51C+V"]\\,$,;G`#&G"9RUX&
M<PO8L$J08M>)\`T=_A^*`&(@M+D';O:!FZD05RJ;%LEFELN:.8SB$0-!RE-F
M\D$R7#HH/,'04$#T$Y;@R$?:F;=6UJZ2SYGG%ZLSS9.N\*.#B^=,<\3"ZG2R
MIRV2Y"IG=]24%K1!AHSJ):/0P)5NM4-`C5C3V0$.<XC#''"M:U[O.M>_GH-"
M71U!AUPY+F%(0A&6701E,[O9SX9V$;B0D5+?^=*A@\,3BJ`$)3S!V^#^MKC#
MW6TE)`$+-Y4(K1MB[9-P@=OFCK>\D]!M>L?;WMTN0A72#9%U`U#49+%#%:B`
MA8(;_.`(3_C!J="%0+\Z(<<>R[`ODEN*^#N%F)9U1"X.:XT[O-@-(31*_OA@
MAY*;_.0H3[G*4<YOA[2;TZ<FRQRX0`4J#-SF-;^YSG/.<YS[_.94(`.QR0C`
MC).$#V&H@L*7SG2F!WWHT'1YK#\R!RP0W.I-S_K2:UY=NTW]VK4^"1^4^X6R
MF_T+73A[VLV^]K*W'>UJ_P(9//5QHB\DXB#Q@XM<)-$X_:'O>_<[WP5/>+ZW
M?..;[JW'+9[X3B^^K:I^)<`]4F,H5_[&K<.\Y3,/Y<UO7@\;>?EI1X+2LYO^
M]*A//>H'#.2'S\_H.R2#W,E`^]K;_O:XSSWNO]`71T=^/5^?"!_8\`4PR)X,
MQI>[W)-_?.8O__C/5S[R9=_[T`<?YF%7+!G0_K!]-'#?^]_W?O?#3_[QFQ_\
M9*B^[UU_$+Q;1+9Z7VV<5AO_O=.?MO/G@][S+U'\U_GW[_5XD,=^07)]`C@0
M'"=DD_<0>I<[#B@[@/81"8@0[K<08U=S/]=S.Y>!'+B!-4=8=M1XV#81>H!U
M6G>"35<%=&=#`"@0+U<0?&!P5U=P,VB"-FB#-3B#!,<%$T<2$SAH"PA`7,`%
M7<`%6$"$0VB$13B$2ZB$2=B$R_6$7/`%AR<2HA=I%>$ZE:>%KL5YL[6%:-*%
MG=>#;R2":':`B->"'X6&_6:&(1>$#=%YN=,^5QAS%H$%W$9O>:@$>[AL2U"%
M?O&#JP9[$/%MW6:(_DO0;8F8!%!E/X*X/B=EB/AV;^K%/W68?>SD;4^PB8>V
MB97(/X]($!4($7N@!WN0!Z=XBJ#G1I<8<H3(A@41BF5B@&@HBQ@&A[`XBVHX
MBKFXA@3X2J_8BW]@B[XHC`E!C"*7A?NG?WNWC,YH?W_1B@S!BPZA!D`0!->(
MC=JXC=>8C=ZH!("(1M>G>!BQ87#V9D`08ND(9^K8CB06!.%8AFKX@@G1!FTF
M9_@8!'(&9^F(C?DH9W'V!'$AC2F$BP#4`F%V`UO&90NID`SYD!!I7T40C[_E
MAM,H:22(BGE@BJBH!QWYD:4(DAY9BAQ)D2%!D`K!:L88BQ:I/[1X@,AH_I"Y
MB)(0AY$/X08M`&9=II-AYF4]N9,[^9-""68S@`,@^'^_B%$4H0<XP&#VU0(N
M0%\+%I5/2953*950B956F95/B0,F67=1QVXO*1!ZP%_W)97]=99FN99JV99/
M&03RF)1Z)),'T08ED`(MH&!XF9?=M6!ZZ9=]R9=[^9>""9AX60)%L$3CB(45
MD04(9P4'!YD&)YD%1YE88)F8&9E6IT1BU)(I&8R]2(ST").>J8`KF1`T28$V
M"1%Q4`(FX%TJ$)NP*9NQ29NU.9OB=9NUF9NV29LMX!R:IH8J*1%9D`%V=9QW
MA9S*F9S,N9S*&8%M.(]C:1!+H`'.V9S8>9W:_LF<)7"4$)&:0*@115`">:E@
MYLF7YYF>Z+F>ZMF>Z!F;):`"T-D0Q$B-#.$'=C"2&XF*^:F1(]F?JLB?^OF?
M`RJ@_JF1=C"?#(&,H)F+HCF=BQ>3IXD0X#E)JWD17F`!'S`"&]JA'/JA'AJB
M(#JB(EJB(+H""GH0#`H2(S!+WO2B,!JC,CJC!]!UT2F7+@BA%F@!#O!-VG1+
M/YI-MN2C0_JC12JD00JD1+I,&]!HA26<="D1:S`!%E"E5GJE6)JE6KJE6SHK
MC+>+%YH1=E`'=%`'9'JF9&H'97JF:HJF9;JF=-"F;/JF9DJG!(:C?S"<$_J@
M$ZJBI=EDI<,'=[!Y_IA7J):W!V28AGAJGRAA!Q+0+C,T0P:@HPCXIX/6H&(A
M!@.```?`J>[2J9WJJ:%Z``6P:0K!IZ:C`Y`:JI[ZJ:YZ``ZP@J2VF*&6.GQ`
M`9$:0P90+&#Y5L86IFZQ!VX0!\3Z!L1:K,<:!\-J?<*)J6PHFL`JC&I@J08A
M!DW`!WC`D7MP!Z5XBMG:K0EJBGJ`!QVYK:DXKMK*K1SYK:88KJ5(KMW*K1WY
MK:BHKMXJKGO@KN-:KO+ZKNG:K:@8!M1:$'!@%CE@`PA;`SJ0L#:PL#6`L#KP
ML`A[L`F[L#;PL`X+L1)K`Q1[L1:+L1>KL0C+L2.KL`R;L0V[L1UKLB&+_K(1
M.[(ZP`)L97=].A(>5;,8<;,X:Q$ZN[.G`V-$$@(.H``2(`3<ZK.^^A!.@!B&
M,0"&\3D+Q1(P(04U@`<&L1).`'IV@`1,L#%\(`5.`!-.\`.-1@<2X@1@ZP1'
MH#`%X05'0`0@:`<[``,_(&5[(`0P4`-1BGT.41\&$"BWFC8$(07?<1X#`%!.
MD!AT4Q@'X3#GD1U0ZP;HD1U>8A!BDB@$`0-.BP!9P[8$\08$4`"XJC50F[0-
M,0*1,K@(,04#<`1[$*=OD&Y9D!U5HAP'804$0`1Z4`=V\`:K.!!UH`9VL",G
M4'(S*Q!OXZ4$82,7$*=GP`#J)Q#-LC-\8`,Q_L`[,,8'[<(8G'F[!-`A"C&[
M#D``36*[5TL`!ODV_8(0R7L0%&``?A,X#((EKY&BD/80>W`TFM$$#``"'[`!
M`E,04R"Z(+`!@KN\!.`%[?('EM*X!C`!(7`!!TRP?I(0[6L0!$`!%=<GAJ$`
M+%"ZIKL0>\`B>,($A`$K3FH%AT$``2`_WM$&1$``1Q`>#HP8`E`#"O$&%<R^
M!Z"\`R$`%)"H1/(#%%`8!G"\(;P0[\LG:K`["=*]?\"ZX>)WC3L`F_*^-'R^
MT?H'<;##!W'!!:$`"!`?PK$0P'(!:O@'4I!!=$,'$)`J!H&[VB6[`U`&?Z#`
MYEL0N,L^9`@'7FRY_CU\$#9``#@L$!3`>I_KN70P)'@J$`%"`!)0+88AOP)A
M(QBP`BMP`B,@3=YAQY]R&/I"`!>`R2NP`6;6Q>O[Q8%L$'G`N1^@`Q`P`!)@
M$",P`!L0LYR[.32K)!>`(A2`H@<!`RCB``S0``A`*@1A`P<`/EG@``L01C8P
MS`S@``:`S-V1`!\@95+@`!#PNP2!!RM`S!-@S0*Q!V'``A"P`(3"JV$9$24'
M:'%J!W=@<L`I$"5GM892<C>%G_),SR`XS_5,$"8':/-<A?EZ!Q+1LTA;&T"[
MT`G=T`[-.S5P>9Q'T19=T1CM>9JWT9W'T1>MT1T=TA_MT1E-TB`]TE#V20<H
M`#PQ4`,P,#PU4#PLS=(P+=/'$]/!0]-Y:],QH-,XW=,WS=,UG=-$;3P_[=-"
<O=-%C=1%/=1`;=0\#3PVX,,17=56?9H!`0``.S\_
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
